RCEL

AVITA MEDICAL, INC.

RCEL · CIK 1762303 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$72M
20202025
Net Income−$49M
20202025
Operating CF−$31M
20202025
Free Cash Flow−$32M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense——————
Operating Income$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.74$-2.39$1.40$1.07$-0.19$-0.60
EPS (Diluted)$-1.74$-2.39$1.40$1.07$-0.19$-0.60

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Current Assets$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B
Total Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Current Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.0B$0.0B$0.0B$0.1B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B
← Companies